Related Experiment Video
Updated: Jul 17, 2025
04:50
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
326
Systemic Treatment for Cholangiocarcinoma
Aumkhae Sookprasert1, Kosin Wirasorn2, Jarin Chindaprasirt2
1Medical Oncology Unit, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand. saumkh@kku.ac.th.
Summary
Cholangiocarcinoma (CCA) treatment varies by stage, including surgery, chemotherapy, and targeted therapies. Research explores molecular alterations for advanced biliary tract cancers, with immunotherapy showing limited efficacy.
Area of Science:
- Oncology
- Gastroenterology
- Molecular Biology
Background:
- Cholangiocarcinoma (CCA) is a biliary tree cancer with varying incidence globally.
- Risk factors and molecular alterations are key to understanding cholangiocarcinogenesis.
- Current treatments include surgery, chemotherapy, and emerging targeted therapies.
Purpose of the Study:
- To provide an overview of current evidence and research in CCA treatment.
- To highlight advancements in chemotherapy, targeted therapies, and immunotherapies.
- To discuss the role of molecular profiling in identifying therapeutic targets.
Main Methods:
- Review of current evidence and ongoing research in cholangiocarcinoma (CCA).
- Analysis of surgical resection, adjuvant, and neoadjuvant chemotherapy efficacy.
- Evaluation of targeted therapies and immunotherapies based on molecular profiling.
Main Results:
- Surgical resection is the primary curative treatment for CCA.
- Adjuvant chemotherapy shows benefits, while neoadjuvant chemotherapy's role is debated.
- Chemotherapy is standard for advanced CCA; molecular targets include FGFR, IDH1, HER2.
- Immunotherapy has limited benefit in advanced CCA.
Conclusions:
- Treatment strategies for CCA are stage-dependent, integrating surgery, chemotherapy, and targeted agents.
- Molecular profiling is crucial for identifying actionable targets in advanced CCA.
- Further research is needed to optimize therapeutic approaches and improve outcomes for biliary tract cancers.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K